 If a subject shows an at least partial response PR on Day 29 or Day 36 4 doses the sponsor discusses with the Data Safety Monitoring Board DSMB to give an additional 2 doses therefore the maximal number of doses for each subject is 6 doses and a further staging will be performed 14 and 21 days after the last dose administration. 